Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Iron Med RX

CoreAge Rx
Graded #1

Higher grade

vs+37
Iron Med RX
Graded #453

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 54.8/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +47
92
45
Dose & formulationCoreAge Rx +37
88
51
Clinical oversightCoreAge Rx +22
93
71
Labs & monitoringCoreAge Rx +38
90
52
FulfillmentCoreAge Rx +37
95
58
Contract termsCoreAge Rx +41
96
55
CoreAge Rx · left barIron Med RX · right bar

The numbers

MetricCoreAge RxIron Med RX
WeighScore91.8/10054.8/100
GradeA−C
Scorecard rank#1#453
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
Iron Med RX

Graded #453 · C

Strengths

  • Unusually broad GLP-1 lineup — compounded semaglutide and tirzepatide in both oral tablets and injection, plus microdosing and longevity add-ons
  • Online process with licensed-provider oversight, virtual consults, progress tracking and home delivery
  • Oral tablet options for people who would rather not inject

Where it loses points

  • Prices are not shown publicly — you only see costs after creating an account, so you cannot compare value upfront
  • Labels its oral semaglutide 'research-grade' — wording usually tied to research/non-prescription peptides; confirm it is prescribed for human use
  • Does not name its compounding pharmacy or list the states it serves; the listed address is a private mailbox (PMB), not a clinic
  • Compounded GLP-1 only — no brand-name or insurance options; small, lightly documented operation

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard